graph Evidence gap map comparisons
abemaciclib based treatmentcyclin inhibitorpalbociclib based treatmentribociclib based treatment
abemaciclib plus aromatase inhibitor abemaciclib plus endocrine therapy abemaciclib plus fulvestrant dalpiciclib plus fulvestrant palbociclib palbociclib plus endocrine therapy palbociclib plus fulvestrant palbociclib plus letrozole ribociclib plus endocrine therapy ribociclib plus fulvestrant ribociclib plus letrozole
Comparator:  vs endocrine therapy;   vs capecitabine;   vs aromatase inhibitor;   vs letrozole;   vs fulvestrant; 
Risk of bias:  low;   some concerns;   high;  NA;